TickerGuard
Buy Day today: Neutral (50) Mixed market breadth · major macro event coming up
BNTX

BioNTech SE

Healthcare · Biotechnology

87.20$ -0.3% vs. previous close Closing price · As of: Nov 10, 2026

Ownership

Ownership Structure

Who owns BioNTech SE (BNTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 42.8% of the shares are freely tradable; institutional investors hold 20.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 20.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 57.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 42.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 248Mio.

Largest Shareholders

Institutions

Institutions BNTX
Name Stake (%) Shares Change (%) Date
FMR Inc 3.05 7,571,805 +32.6 06/30/2026
PRIMECAP Management Company 1.52 3,772,031 -0.6 06/30/2026
Dodge & Cox 1.48 3,677,591 +0.0 06/30/2026
Flossbach von Storch AG 0.90 2,226,138 -39.5 06/30/2026
T. Rowe Price Investment Management,Inc. 0.83 2,065,456 -64.7 06/30/2026
BlackRock Inc 0.75 1,854,966 +11.9 06/30/2026
Temasek Holdings Ltd. 0.61 1,506,027 +0.0 06/30/2026

Funds

Funds BNTX
Name Stake (%) Shares Change (%) Date
Fidelity Contrafund 1.70 4,210,249 +9.4 09/30/2026
Dodge & Cox International Stock I 1.02 2,517,713 +0.0 09/30/2026
Vanguard Capital Opportunity Inv 0.88 2,189,120 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 9, 2026 Sahin Ugur Chief Executive Officer Sell 36,209 95.37 3,453,372
Oct 8, 2026 Sahin Ugur Chief Executive Officer Sell 27,000 92.31 2,492,483
Oct 7, 2026 Sahin Ugur Chief Executive Officer Sell 24,000 95.86 2,300,633
Oct 6, 2026 Sahin Ugur Chief Executive Officer Sell 21,000 96.81 2,032,995
Oct 5, 2026 Sahin Ugur Chief Executive Officer Sell 72,000 97.23 7,000,646
Oct 2, 2026 Sahin Ugur Chief Executive Officer Sell 17,000 96.72 1,644,323
Oct 1, 2026 Sahin Ugur Chief Executive Officer Sell 17,000 97.46 1,656,745
Sep 30, 2026 Sahin Ugur Chief Executive Officer Sell 32,000 98.12 3,139,850
Sep 29, 2026 Sahin Ugur Chief Executive Officer Sell 34,000 98.26 3,340,809
Sep 28, 2026 Sahin Ugur Chief Executive Officer Sell 34,000 98.47 3,347,919
Sep 25, 2026 Sahin Ugur Chief Executive Officer Sell 27,000 98.69 2,664,581
Sep 24, 2026 Sahin Ugur Chief Executive Officer Sell 39,000 98.99 3,860,661
Sep 23, 2026 Sahin Ugur Chief Executive Officer Sell 30,000 99.40 2,982,081
Sep 22, 2026 Sahin Ugur Chief Executive Officer Sell 46,000 100.72 4,633,037
Sep 21, 2026 Sahin Ugur Chief Executive Officer Sell 33,000 97.81 3,227,720
Sep 18, 2026 Sahin Ugur Chief Executive Officer Sell 30,000 96.22 2,886,729
Sep 17, 2026 Sahin Ugur Chief Executive Officer Sell 34,000 98.60 3,352,342
Sep 16, 2026 Sahin Ugur Chief Executive Officer Sell 15,000 96.09 1,441,340
Sep 15, 2026 Sahin Ugur Chief Executive Officer Sell 34,000 96.49 3,280,636
Sep 14, 2026 Sahin Ugur Chief Executive Officer Sell 41,000 99.45 4,077,315
Sep 11, 2026 Sahin Ugur Chief Executive Officer Sell 45,000 96.93 4,362,021
Sep 10, 2026 Sahin Ugur Chief Executive Officer Sell 20,500 96.31 1,974,287
Sep 9, 2026 Sahin Ugur Chief Executive Officer Sell 36,000 97.78 3,520,145
Sep 8, 2026 Sahin Ugur Chief Executive Officer Sell 37,000 99.20 3,670,518
Sep 4, 2026 Sahin Ugur Chief Executive Officer Sell 31,500 103.52 3,260,823
Sep 3, 2026 Sahin Ugur Chief Executive Officer Sell 45,000 102.85 4,628,232
Apr 22, 2026 Sierk Poetting COO Sell 50,000 110.56 5,528,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 10, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?